Browse by author
Lookup NU author(s): Seb Aspinall, Dr David Cook, Dr Brian Shenton, Andrew Griffiths, Clive Griffith, Richard Bliss, Professor Thomas Lennard
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Several studies have found elevated levels of adrenal androgens in postmenopausal women and depressed levels in premenopausal women with breast cancer, suggesting a role for adrenal androgens in the aetiology of breast cancer. We have measured serum dehydroepiandrosterone sulphate and androstenedione in 81 women with primary operable breast cancer and 62 age-matched controls. Results showed that serum levels of both adrenal androgens fell significantly with age in women with breast cancer (P = 0.003). However, no relationship was observed between serum adrenal androgen levels and body mass index in either women with breast cancer or controls. Dehydroepiandrosterone sulphate levels were elevated in postmenopausal women with breast cancer compared to controls, and this was not due to preoperative stress. No differences were observed in androstenedione levels between premenopausal or postmenopausal women with breast cancer and controls, nor were dehydroepiandrostenedione sulphate levels significantly different between premenopausal women with breast cancer and controls. These results suggest that dehydroepiandrosterone sulphate has a role in the aetiology of postmenopausal breast cancer. © 2003 Elsevier Science Ltd. All rights reserved.
Author(s): Aspinall, S., Cook, D., Shenton, B.K., Griffiths, A., Griffith, C., Bliss, R., Lennard, T.W.J.
Publication type: Article
Publication status: Published
Journal: Breast
Year: 2003
Volume: 12
Issue: 1
Pages: 63-71
Print publication date: 01/02/2003
ISSN (print): 0960-9776
ISSN (electronic): 1532-3080
URL: http://dx.doi.org/10.1016/S0960-9776(02)00264-3
DOI: 10.1016/S0960-9776(02)00264-3
PubMed id: 14659357
Altmetrics provided by Altmetric
